Searchable abstracts of presentations at key conferences in endocrinology

ea0063p413 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Phenotypic variability within a family with multiple endocrine neoplasia type 1 (MEN1) syndrome

Ahmad Tariq , Sharma Jayant , Crowley Rachel , Kyithar Ma Pyeh

MEN1 is an autosomal dominant endocrine tumour syndrome, caused by inactivating mutations of the MEN1 tumour suppressor gene at 11q13 locus and characterised by occurrence of hyperparathyroidism, pancreatic tumours and pituitary adenomas. We describe a family with MEN1 syndrome. The index case was a 71-year-old man, referred to Endocrinology clinic in Midland Regional Hospital Portlaoise for hypercalcemia (calcium 3 mmol/l, phosphate 0.5 mmol/l, PTH 350 pg/ml, creatin...

ea0049gp88 | Diabetes & complications 2 | ECE2017

Effect of insulin on neurotrophins’ levels in the muscular wall of mice intestine and colon

Alqudah Mohammad , Mustafa Ayman , Allouh Mohammad , Alshboul Othman , AlDwairi Ahmad

Background: Neurotrophins are implicated in the physiology and pathophysiology of the mature gastrointestinal tract (GIT) such as motility and inflammatory bowel disease. Moreover, GIT disturbances has been attributed to hyperinsuliemia. Insulin-neurotrophins interactions in the (GIT) have not been investigated yet.Aim: To test the effect of Insulin on the expression of neurotrophins in the muscular wall of mice intestine and colon.<p class="abstext"...

ea0044p43 | Bone and Calcium | SFEBES2016

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

Whittingham Pauline , Grounds Kerrie , Ahmad Aftab , Didi Mo , Corlett Pamela

Introduction: Previous audits demonstrated low bone mineral density (BMD) in adolescent patients with hormone deficiencies. We wanted to ascertain if gender had any relationship with the development of low BMD.Method: A retrospective analysis of 42 Transitional clinic patients who underwent DEXA scanning was made using case notes and hospital systems. Follow-up data was gathered as previous audit of 25 transitional patients had shown a significant number...

ea0044p76 | Clinical biochemistry | SFEBES2016

Time taken for GH-treated adolescent patients, transitioning to adult services, to reach IGF1 levels within the upper normal range: Do we need to monitor more frequently?

Grounds Kerrie , Whittingham Pauline , Didi Mo , Ahmad Aftab

Introduction: According to NICE: adults receiving growth hormone (GH) treatment, IGF1 levels should reach therapeutic range by 9 months. Patients are reviewed at 1, 3, 6, 9, 12 months and 6 months thereafter in our clinics. GH dose is titrated by 0.1 mg each visit. This work aims to compare the time it takes to get the IGF1 in range, between adults and adolescent patients attending our specialist regional clinics.Method: We performed a retrospective audi...

ea0044ep62 | (1) | SFEBES2016

Protienurea, oedema, murmur and skin rash – an interesting case of gut carcinoids

Nizamuddin Khwaja , Ahmad Sajjad , Thaman Rajesh , Glover David

A 52 years old man was referred to the renal clinic for persistent proteinurea and leg swelling with suspicion of nephrotic syndrome. He had a history of Hypertension and chronic depression and was taking olanzapine, venlafaxine, Ramipril.He also had diarrhoea of 5–6 stools per day over the last 6 months. He was getting short of breath and had lost weight. On examination he had erythematous rash over the face, limbs and abdomen which he mentioned was exacerbated by stress...

ea0041ep83 | Adrenal cortex (to include Cushing's) | ECE2016

Depression and acute kidney injury – unusual presentation of Addison’s disease

Ahmad Sajjad , Khalily Naveed , Vernavos Petros , Bondugulapati Laxmi Narsimharao

Introduction: Addison’s disease is the commonest cause of primary hypoadrenalism in the western world. Here, we discuss a case of Addison’s with unusual presentation.Case report: A 39-year-old woman with no previous mental health problems was admitted with history of worsening depression over the last 15 months following her divorce. She had low mood and anhedonia in spite of sertraline for more than a year. This was associated with 40 kg weigh...

ea0035p478 | Diabetes therapy | ECE2014

Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study

Saad Farid , Haider Ahmad , Doros Gheorghe , Traish Abdulmaged

Background: Hypogonadism is associated with cardiometabolic risk. Studies suggest that hypogonadism increases the risk of all-cause and cardiovascular mortality. While some short-term studies have been performed in men with CVD, there are no data on long-term effects of testosterone replacement therapy (TRT) in men with CVD.Methods: In a prospective, cumulative, observational registry study from a single urologist’s office, 300 men with testosterone...

ea0035p754 | Obesity | ECE2014

Meaningful and sustained weight loss and improvement of lipid profile in hypogonadal men on long-term treatment with testosterone undecanoate (TU) injections are independent of age: observational data from two registry studies

Saad Farid , Haider Ahmad , Yassin Aksam , Doros Gheorghe , Traish Abdulmaged

Introduction: Improvements of anthropometric and metabolic parameters on long-term testosterone replacement therapy (TRT) from our registry studies have been reported in 2013 (Saad, Obes; Yassin and Doros, Clin Obes; Traish, Int J Clin Pract).Methods: Five hundred and sixty-one hypogonadal men from both registry studies were divided into age groups ≤65 (Group A, n=450) and >65 years (Group B, n=111). All men were treated with ...

ea0035p755 | Obesity | ECE2014

Anthropometric and metabolic parameters in 46 hypogonadal men with obesity grade III improve upon long-term treatment with testosterone undecanoate (TU) injections: Observational data from two registry studies

Saad Farid , Haider Ahmad , Yassin Aksam , Doros Gheorghe , Traish Abdulmaged

Introduction: Numerous studies have reported inverse associations between testosterone and obesity as well as other components of the metabolic syndrome.Methods: From two registry studies of 561 hypogonadal mens, 46 mens with obesity grade III (BMI ≧40 kg/m2) were selected. All patients received TU injections for up to 6 years. 46 mens were followed for 2 years, 43 for 3 years, 37 for 4 years, 34 for 5 years, and 24 for 6 s. Declining n...

ea0058p029 | Miscellaneous Endocrinology | BSPED2018

Using CRISPR/Cas9gene editing to study the molecular genetics of congenital hyperinsulinism

Purushothaman Preetha , Aldossary Ahmad , Guerrini Ileana , Hart Stephen , Hussain Khalid

Background: Congenital Hyperinsulinism (CHI) is characterized by the unregulated secretion of insulin in the presence of hypoglycaemia. The mutations in ABCC8 and KCNJ11, which encode the sulfonylurea receptor 1 (SUR1) and potassium inward-rectifying 6.2 (Kir6.2) subunits of ATP-sensitive potassium channel (K channel), are the most common identified cause of the condition.Aims: The aim is to use the novel CRISPR/Cas9 gene editing technique to create a KO...